Caroline Tiemessen to Disease Progression
This is a "connection" page, showing publications Caroline Tiemessen has written about Disease Progression.
Connection Strength
0,900
-
Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clin Immunol. 2019 08; 205:16-24.
Score: 0,157
-
The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression. Genes Immun. 2019 11; 20(8):651-659.
Score: 0,153
-
RICH2 is implicated in viraemic control of HIV-1 in black South African individuals. Infect Genet Evol. 2017 04; 49:78-87.
Score: 0,134
-
CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations. Immunogenetics. 2012 Nov; 64(11):795-806.
Score: 0,099
-
Marked differences in CCR5 expression and activation levels in two South African populations. Immunology. 2012 Aug; 136(4):397-407.
Score: 0,098
-
Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):245-54.
Score: 0,074
-
Circulating levels of stromal cell-derived factor 1alpha and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes. AIDS Res Hum Retroviruses. 2003 Jun; 19(6):461-8.
Score: 0,052
-
Human immunodeficiency virus type 1 envelope-stimulated interleukin-2 production and survival of infected children with severe and mild clinical disease. J Infect Dis. 2001 Sep 15; 184(6):691-8.
Score: 0,046
-
Partner HIV Serostatus Impacts Viral Load, Genital HIV Shedding, and Immune Activation in HIV-Infected Individuals. J Acquir Immune Defic Syndr. 2019 09 01; 82(1):51-60.
Score: 0,040
-
Prevalence of premalignant cervical lesions in women with a long-term nonprogressor or HIV controller phenotype. J Acquir Immune Defic Syndr. 2014 Jan 01; 65(1):e29-32.
Score: 0,027
-
Reply to: "Experimental aspects of copy number variant assays at CCL3L1". Nat Med. 2009 Oct; 15(10):1117-20.
Score: 0,020